Quantamental Technologies’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$988K Buy
+9,594
New +$1.03M 0.93% 10
2023
Q2
Sell
-4,598
Closed -$489K 585
2023
Q1
$489K Buy
+4,598
New +$496K 0.26% 126
2022
Q4
Sell
-9,045
Closed -$779K 587
2022
Q3
$779K Buy
+9,045
New +$807K 0.3% 102
2022
Q2
Sell
-4,155
Closed -$341K 502
2022
Q1
$341K Sell
4,155
-6,295
-60% -$496K 0.2% 204
2021
Q4
$801K Buy
+10,450
New +$832K 0.41% 72
2020
Q4
Sell
-13,931
Closed -$1.1M 209
2020
Q3
$1.1M Sell
13,931
-8,514
-38% -$667K 0.81% 30
2020
Q2
$1.66M Buy
+22,445
New +$1.69M 1.11% 12
2020
Q1
Sell
-7,035
Closed -$611K 292
2019
Q4
$611K Buy
7,035
+5,552
+374% +$456K 0.31% 90
2019
Q3
$119K Sell
1,483
-4,340
-75% -$348K 0.04% 667
2019
Q2
$466K Buy
5,823
+4,625
+386% +$354K 0.17% 156
2019
Q1
$95K Sell
1,198
-292
-20% -$21.8K 0.04% 626
2018
Q4
$109K Buy
+1,490
New +$105K 0.07% 521

Other funds holding MRK

Quantamental Technologies's MRK Position: Q3 2023 in Review

Quantamental Technologies opened a new position in Merck (MRK) in Q3 2023: 9,594 shares worth $988K. The stake represents 0.93% of the portfolio and ranks #10 among its holdings. This is a return to the name: Quantamental Technologies previously reported a position in MRK as recently as Q1 2023.

Quantamental Technologies first reported a position in MRK in Q4 2018 and has held it in 12 quarters since. The position peaked at $1.66M in Q2 2020. 3,214 funds tracked by Wall St. Rank hold MRK as of Q3 2023.

  • Quantamental Technologies held 9,594 shares of Merck worth $988K as of Q3 2023.
  • Merck was a new Quantamental Technologies position in Q3 2023.
  • Merck made up 0.93% of Quantamental Technologies's portfolio in Q3 2023, its #10 holding.
  • Quantamental Technologies first reported a position in Merck in Q4 2018 and has held it in 12 quarters since.
  • Quantamental Technologies's Merck position peaked at $1.66M in Q2 2020.
  • 3,214 funds tracked by Wall St. Rank held Merck as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.